Italy has had a national health service since 1978, to provide access to care to all citizens. The service uses 3-year plans to aim to meet demands and needs. The pharmaceutical sector is well developed with regard to R & D and production. Drug prices are fixed based on comparison prices in other European countries. Position within 3 classes of drugs determines the level of patient co-payment. Genetics have been recognized and included since 1996. Numerous recent events are likely to change the pharmaceutical sector, since recent regulations have not succeeded in reducing prices or utilization.
|Titolo:||Pharmaceutical expenditure: Aspects of cost containment in Italy|
MINGHETTI, PAOLA (Penultimo)
|Parole Chiave:||Drug reimbursement; Generic drugs; National health service|
|Settore Scientifico Disciplinare:||Settore CHIM/09 - Farmaceutico Tecnologico Applicativo|
|Data di pubblicazione:||2003|
|Digital Object Identifier (DOI):||10.1300/J371v12n04_06|
|Appare nelle tipologie:||01 - Articolo su periodico|